Article
Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients.
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology - 1 Dec 2020
Turken Melda, Kose Sukran, Colak Ergun Nadide, Tatar Bengu
Abstract excerpt
BACKGROUND AND STUDY AIMS: Rapid virologic response (RVR) is defined as undetectable hepatitis C virus (HCV) RNA in serum after 4 weeks of treatment for chronic hepatitis C (CHC). Paritaprevir/ritonavir/ombitasvir (PRO) and/or dasabuvir (D), with or without ribavirin [PRO (D) ± ribavirin], which are direct-acting antivirals (DAAs), is the currently approved treatment regimen for CHC genotype 1; this regimen can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
